Related topics: Preclinical Research, Preclinical
US CRO staffing and functional specialist ASG has purchased contract research firm Ockham, furthering its evolution into a one-stop clinical contracting firm.
The all stock merger, financial terms of which have not being released, creates a company that can offer a full range of contract research capabilities to drug developers in addition to ASG’s traditional strength in providing services to contract research organisations (CRO).
The combined firm will employ more than 240 staff worldwide and is projected to have a turnover of some $30m (€24m) a year.
Copyright - Unless otherwise stated all contents of this web site are © 2000/2010 - Decision News Media SAS - All Rights Reserved - For permission to reproduce any contents of this web site, please email our Syndication department: Administration & Finance - Full details for the use of materials on this site can be found in the Terms & Conditions
